Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Current Assets: 2020-2024

Historic Current Assets for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Dec 2024 value amounting to $392.8 million.

  • Mirum Pharmaceuticals' Current Assets rose 37.23% to $530.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $530.6 million, marking a year-over-year increase of 37.23%. This contributed to the annual value of $392.8 million for FY2024, which is 1.35% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Current Assets stood at $392.8 million for FY2024, which was up 1.35% from $387.5 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Current Assets peaked at $392.8 million during FY2024, and registered a low of $166.6 million during FY2021.
  • Its 3-year average for Current Assets is $323.5 million, with a median of $387.5 million in 2023.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Current Assets declined by 29.51% in 2021, and later soared by 103.73% in 2023.
  • Mirum Pharmaceuticals' Current Assets (Yearly) stood at $236.3 million in 2020, then fell by 29.51% to $166.6 million in 2021, then rose by 14.19% to $190.2 million in 2022, then skyrocketed by 103.73% to $387.5 million in 2023, then grew by 1.35% to $392.8 million in 2024.